Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers

Cancer Science

Volumn 94, Issue 7, 2003, Pages 612-617

  Masuda, Norihiro ^a   Kato, Hiroyuki ^a   Nakajima, Takashi ^a   Sano, Takaaki ^a   Kashiwabara, Kenji ^a   Oyama, Tetsunari ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P21; PROTEIN P73;

ADULT; ADVANCED CANCER; AGED; BASAL CELL; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW;

DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); TUMOR SUPPRESSOR PROTEINS;

EID: 0043063959     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01491.x     Document Type: Review

References (53)

1. Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Kitamura K, Mori M, Kuwano H. Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 1994; 178: 363-8.
2. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan. 3rd ed. Chiba: 2002.
3. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998; 123: 432-9.
4. Kuwano, H, Masuda N, Kato H, Sugimachi K. The subepithelial extension of esophageal carcinoma for determining the resection margin during esophagectomy: a serial histopathologic investigation. Surgery 2002; 131: S14-21.
5. Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M, Ishizaki K. Genetic alterations in patients with esophageal cancer with short-and long-term survival rates after curative esophagectomy. Ann Surg 1997; 22: 62-8.
6. Shiozaki H, Doki Y, Kawanishi K, Shamma A, Yano M, Inoue M, Monden M. Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surgery 2000; 127: 552-61.
7. Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002; 15: 737-43.
8. Miyazaki T, Kato H, Shitara Y, Yoshikawa M, Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T, Kuwano H. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 2000; 89: 955-62.
9. Watanabe M, Kuwano H, Tanaka S, Toh Y, Masuda H, Sugimachi K. A significant morphological transformation is recognized in human esophageal cancer cells with an amplification/overexpression of the cyclin D1 gene. Int J Oncol 1999; 15: 1103-8.
10. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Res 2000; 20: 345-9.
11. Maesawa C, Tamura G, Nishizuka S, Ogasawara S, Ishida K, Terashima M, Sakata K, Sato N, Saito K, Satodate R. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res 1996; 56: 3875-8.
12. Fong LY, Nguyen VT, Farber JL, Huebner K, Magee PN. Early deregulation of the p16ink4a-cyclin D1/cyclin-dependent kinase4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats. Cancer Res 2000; 60: 4589-95.
13. Nie Y, Liao J, Zhao X, Song Y, Yang GY, Wang LD, Yang CS. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002; 10: 1713-20.
14. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
15. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19: 607-14.
16. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87: 9958-61.
17. Yasuda M, Kuwano H, Watanabe M, Toh Y, Ohno S, Sugimachi K. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer 2000; 83: 1033-8.
18. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-19.
19. Jost CA, Marin MC, Kaelin WG Jr. p73 is a human p53-related protein that can induce apoptosis. Nature 1997; 389: 191-4.
20. Zhu J, Jiang J, Zhou W, Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 1998; 58: 5061-5.
21. Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno S, Nimura Y, Nakagawara A, Horii A. Infrequent somatic mutations of the p73 gene in various human cancers. Eur J Surg Oncol 1999; 25: 194-8.
22. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping YM, Nakagawara A. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer 1998; 78: 437-40.
23. Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI, Liu W. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 1999; 18: 1629-33.
24. Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 1999; 59: 3257-63.
25. Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, Chi SG. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000; 6: 1767-71.
26. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999; 59: 3352-6.
27. Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, Rivas C, Fernandez-Piqueras J, Benitez J. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas. Int J Cancer 2002; 102: 15-9.
28. Dong S, Pang JC, Hu J, Zhou LF, Ng HK. Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer, 2002; 98: 370-5.
29. Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY. p73 gene expression in ovarian cancer tissues and cell lines. Clin Cancer Res 2000; 6: 3910-5.
30. Kamiya M, Nakazato Y. The expression of p73, p21 and MDM2 proteins in gliomas. J Neurooncol 2002; 59: 143-9.
31. Faridoni-Laurens L, Bosq J, Janot F, Vayssade M, Le Bihan ML, Kaghad M, Caput D, Berard J, Ahomadegbe JC. p73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001; 20: 5302-12.
32. Shirakawa Y, Naomoto Y, Kimura M, Kawashima R, Yamatsuji T, Tamaki T, Hamada M, Haisa M, Tanaka N. Topological analysis of p21WAF1 /CIP1 expression in esophageal squamous dysplasia. Clin Cancer Res 2000; 6: 541-50.
33. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, Bartek J, Bosch FX. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 1997; 74: 383-9.
34. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-703.
35. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP, Harris CC. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992; 52: 6092-7.
36. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993; 53: 846-50.
37. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-602.
38. Seery JP. Stem cells of the oesophageal epithelium. J Cell Sci 2002; 115: 1783-9.
39. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98: 3156-61.
40. Takubo K, Tsuchiya S, Fukushi K, Shirota A, Mitomo Y. Dysplasia and reserve cell hyperplasia-like change in human esophagus. Acta Pathol Jpn 1981; 31: 999-1013.
41. Morita M, Kuwano H, Yasuda M, Watanabe M, Ohno S, Saito T, Furusawa M, Sugimachi K. The multicentric occurrence of squamous epithelial dysplasia and squamous cell carcinoma in the esophagus. Cancer 1994; 74: 2889-95.
42. Kitamura K, Kuwano H, Yasuda M, Sonoda K, Sumiyoshi K, Tsutsui S, Kitamura M, Sugimachi K. What is the earliest malignant lesion in the esophagus? Cancer 1996; 77: 1614-9.
43. Kuwano H, Matsuda H, Matsuoka H, Kai H, Okudaira. Y, Sugimachi K. Intra-epithelial carcinoma concomitant with esophageal squamous cell carcinoma. Cancer 1987; 59: 783-7.
44. Soga J, Tanaka O, Sasaki K, Kawaguchi M, Muto T. Superficial spreading carcinoma of the esophagus. Cancer 1982; 50: 1641-5.
45. Yang G, Zhang Z, Liao J, Seril D, Wang L, Goldstein S, Yang CS. Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int J Cancer 1997; 72: 746-51.
46. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG Jr. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407: 645-8.
47. Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002; 30: 1859-67.
48. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002; 33: 158-64.
49. Araki D, Uzawa K, Watanabe T, Shiiba M, Miyakawa A, Yokoe H, Tanzawa H. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int J Oncol 2002; 20: 355-60.
50. Lam KY, Law S, Tin L, Tung PH, Wong J. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Am J Gastroenterol 1999; 94: 2060-8.
51. Nita ME, Nagawa H, Tominaga O, Tsuno N, Hatano K, Kitayama J, Tsuruo T, Domene CE, Muto T. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Ann Surg Oncol 1999; 6: 481-8.
52. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T, Kuwano H. Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 2001; 167: 65-72.
53. Michieli P, Chedid M, Lin D, Pierce WE, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-5.